4,100 Shares in Astera Labs, Inc. $ALAB Purchased by Trilogy Capital Inc.

Trilogy Capital Inc. acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 4,100 shares of the company’s stock, valued at approximately $371,000.

Other hedge funds have also bought and sold shares of the company. Alliancebernstein L.P. raised its holdings in Astera Labs by 114.2% in the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock worth $501,289,000 after buying an additional 4,478,741 shares during the last quarter. Atreides Management LP raised its holdings in Astera Labs by 153.3% in the first quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock worth $277,601,000 after buying an additional 2,815,614 shares during the last quarter. Bank of Nova Scotia raised its holdings in Astera Labs by 3,742.2% in the first quarter. Bank of Nova Scotia now owns 964,400 shares of the company’s stock worth $57,546,000 after buying an additional 939,300 shares during the last quarter. Jump Financial LLC purchased a new position in Astera Labs in the first quarter worth about $32,998,000. Finally, Pacer Advisors Inc. purchased a new position in Astera Labs in the first quarter worth about $29,935,000. Institutional investors own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. Needham & Company LLC lifted their target price on shares of Astera Labs from $100.00 to $170.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Jefferies Financial Group lifted their target price on shares of Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a report on Tuesday, July 22nd. CICC Research assumed coverage on shares of Astera Labs in a report on Friday, August 29th. They issued an “outperform” rating and a $190.00 target price for the company. Evercore ISI lifted their target price on shares of Astera Labs from $104.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, August 6th. Finally, Susquehanna boosted their price objective on shares of Astera Labs from $80.00 to $125.00 and gave the company a “neutral” rating in a report on Thursday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $155.71.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 91,441 shares of the company’s stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the sale, the chief operating officer directly owned 2,170,877 shares of the company’s stock, valued at approximately $398,377,638.27. This represents a 4.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the sale, the director directly owned 385,863 shares of the company’s stock, valued at approximately $66,858,482.01. This represents a 32.17% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,482,036 shares of company stock valued at $230,685,952 in the last quarter. Insiders own 12.50% of the company’s stock.

Astera Labs Trading Down 0.7%

Shares of ALAB stock opened at $194.50 on Thursday. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The stock has a market cap of $32.33 billion, a P/E ratio of 347.32, a P/E/G ratio of 4.97 and a beta of 1.43. The company has a 50 day simple moving average of $186.50 and a two-hundred day simple moving average of $117.29.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business had revenue of $191.93 million during the quarter, compared to analysts’ expectations of $172.46 million. During the same period in the prior year, the company earned $0.13 earnings per share. The firm’s revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.